Celldex Therapeutics (CLDX) ) Reports Q4 Results

Celldex Therapeutics, Inc. (CLDX) shares are up 0.70% to $24.90 in pre-market trading Tuesday following the company’s fourth quarter earnings results. The clinical-stage firm reported earnings of ($0.36) per share on revenues of $1.5 million, up 150% from a year ago. Analysts were expecting EPS of ($0.34) on revenues of $490K. Net loss came in […] View the full post at: Celldex Therapeutics (CLDX) ) Reports Q4 Results Related posts: Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock JPMorgan Posts Better-than-Expected Results